3SOF

BULLET POINTS TO PONDER.......


SIGNS AGREEMENT: Xinhua Finance Media (XFML) announced that The Yucaipa Companies
("Yucaipa"), an investment firm with holdings in Asia, Europe and the Americas, has signed an
agreement to purchase a block of existing shares from certain shareholders who have come out
of IPO lockup. David Olson, a Yucaipa partner, has agreed to join the board of XFMedia as an
independent director in connection with the transaction.
______________________________________________________________


RECEIVES $15M GRANT: GeoVax Labs, Inc. (GOVX), an Atlanta based biotechnology company,
announced receipt of an estimated $15,000,000 Integrated Preclinical/Clinical AIDS Vaccine
Development [IPCAVD] Grant to support its HIV/AIDS vaccine program. This large Grant was
awarded by the National Institutes of Health-National Institute of Allergy & Infectious Disease
[NIH-NIAID], an agency of the U.S. Government. Funding commences October 2007.
______________________________________________________________



COMPLETES LAUNCH: Secured Financial Network (SFNL) announced that the Company has
completed the build-out and official launch of its proprietary Payment Gateway, which going
forward will be marketed to both online and offline merchants under the "The RedFin Network"
brand name.
____________________________________________________________



BEGINS DOSING FIRST PATIENTS IN PH IB TRIAL: InterMune, Inc. (ITMN) announced that
the company has begun dosing the first patients in their Phase 1b multiple ascending dose
(MAD) clinical trial evaluating ITMN-191 (also called R7227) in patients with chronic hepatitis
C. ITMN-191 is a hepatitis C virus (HCV) protease inhibitor in development by InterMune and
its partner, Roche. InterMune also reported additional information from its recently completed
Phase 1a clinical trial of ITMN-191.
_____________________________________________________________



GRANTED PATENT: RAE Systems Inc. (RAE) was granted United States Patent Number
7,258,773 B2 for the first Solid Polymer Electrolyte (SPE(TM)) Oxygen Sensor. The patent included
54 claims. This sensor technology will find applications in the industrial safety and first responder
markets worldwide. Compared to other type oxygen sensors, it is unique in that is uses
a solid polymer in combination with normally available air and moisture rather than the traditional
hazardous electrolyte and lead wool. Three to five million oxygen sensors are currently being
used in industrial applications. This new SPE O2 sensor is already available in RAE Systems'
QRAE II four-gas monitor .
_____________________________________________________________



RECEIVES $572K ORDER: ICOP Digital, Inc. (ICOP) announced that the Company has received
a purchase order totaling $572,000 from the Alaska State Troopers for its ongoing deployment
of ICOP Model 20/20(R)-W digital in-car video systems in its patrol fleet.
INITIATES PHASE 2 CLINICAL TRIAL: Nastech Pharmaceutical Company Inc. (NSTK) announced
the start of a Phase 2 clinical trial evaluating the Company's rapid-acting Insulin Nasal
Spray in approximately 20 patients with type 2 diabetes. The study is a randomized, crossover
study evaluating formulations of Insulin Nasal Spray as compared to NovoLog(R) insulin aspart
(rDNA origin), an approved, rapid-acting injectable insulin, on post-meal glycemic control.
Data from Nastech's earlier Phase 1 pharmacokinetic and safety studies demonstrated that the
Company's Insulin Nasal Spray achieved faster time to maximum plasma levels than NovoLog
injection and Exubera(R) (insulin human [rDNA origin]) Inhalation Powder in healthy subjects.
Additionally, the intranasal formulations tested were well-tolerated and did not show any clinically
significant hypoglycemia.
___________________________________________________________



COMPLETES PRIME NATURAL ACQUISITION: True North Energy Corporation (TNEN) is
pleased to announce that it has closed the acquisition of Prime Natural Resources Inc., interests
in the Devon Fee Gas Unit and the O'Leary Gas Unit No. 1 in Brazoria County, Texas. "We look
at this transaction as a first of several that will add proven producing assets, with low risk exploitation
potential, to the foundation part of our portfolio," said John Folnovic, True North Energy
President and CEO.
___________________________________________________________



SIGNS LOI TO ACQUIRE 50% STAKE: GlobeTel Communications Corp. (GTEM), parent company
of Sanswire Networks LLC (Sanswire), and TAO Technologies GmbH, Stuttgart, Germany
announced that the two companies have signed a letter of intent whereby GlobeTel will purchase
50% of TAO, and TAO will be renamed Sanswire-TAO GmbH. The company will be focused on
the design, development and production of unmanned aerial vehicles. It is expected that Sanswire-
TAO will be based chiefly in Stuttgart, and maintain a presence in both Berlin and California.
The acquisition of 50% of TAO follows the October 2005 development agreement between
Sanswire and TAO that resulted in the construction and testing of the Sanswire 2A. The letter of
intent calls for TAO and GlobeTel/Sanswire to share sales and marketing rights of various aerial
vehicles developed and currently owned by TAO. Additionally, upon closing of definitive agreements,
TAO will grant to Sanswire-TAO the respective patents and intellectual property rights
covering the products, including the AirChain segmented airship. Sanswire assets, including
the 2A Technology Demonstrator Stratellite(TM), are being shipped to TAO's German facility to
incorporate design changes based upon flight test data from the ship's test flights, and, specifically,
advances made by TAO since the Sanswire 2A was originally designed.

▲TOP NEWS GAINERS.......

SYMBOL    CLOSE    %GAIN    VOLUME    NEWS
TEXG $0.750 200.00% 76,300 Appoints Dean Elliott to President; Jeffrey Joyce to CEO; Both to the BoD

NNBP $0.165 39.83% 4,284,600 Operational Finance Initiative Includes 20% Buyback, Investor Pursuit

MWXI $8.000 32.23% 14,100 Names New Board of Directors to Company, To Bring Industry Experience

CHNG $7.400 28.70% 1,183,000 Receives Govt Approval to Pursue Diversified Natural Gas Project

TDON $0.790 27.42% 196,800 Appoints Dan DiLeo to the Board of Advisors

MIVT $0.430 16.22% 574,300 Research Collaboration w/Smith & Nephew

SOLUQ $0.490 13.95% 3,936,500 Consensual Plan of Reorganization; Resolution of All Litigation

JSDA $11.440 11.50% 2,268,200 Announces Release of Seattle Seahawks Themed Sodas

VSR $8.000 11.27% 318,600 Awarded $225 Million Contract with $25 Million Plus for Versar

PGIC $5.110 4.93% 220,600 Signs Definitive Agreement for Sale of Worldwide Table Game Division

RMCF $17.030 4.16% 20,100 Q2 EPS 20c vs 16c EPS +25% Y/Y

NEOG $22.950 3.94% 186,800 Q1 EPS 21c vs 17c Beats 19c Est

JAV $5.200 1.96% 282,000 Awarded Patent for Nasal Formulation of Ketamine for Pain

TOP STORIES.......

(CRGN)
Cash Rich Biopharm
CuraGen Refocuses on Oncology
The markets Friday seemed some what leery of the Fed's decision in
the next few weeks on their interest rates. Multiple Fed speakers have
the market on edge with comments suggesting "markets shouldn't bake
into the cake more cuts", "Reasons for Sept 18 rate cut haven't gone
away", "deeper market turmoil could hurt job stability", and "financial
fragility is still an issue", "moderation in inflation allowed a rate cut, but
inflation is still at the upper bounds of the comfort zone". The comments
were confusing and somewhat misleading. The Fed just cut their rate by
50 basis points, but still point to inflation. The market rallied following the
initial announcement but has stalled since. With the 50 basis point cut,
the Fed caught many shorts off guard, and have even alluded to catching
them off guard again with past and Friday's comments. Basically it
seems like they want the bears to sit on the sidelines while the housing
instability runs its course. With so much speculation and uncertainty
surrounding the market, it might be time to find the 'safe' places to put
money. Under the mattress is certainly one place that comes to mind. In
the ground is another. Mining stocks that have large reserves and are
awaiting regulatory approval have popped up on many radar screens.
Another place that has always been somewhat safe is cash rich biopharmaceuticals.
CuraGen Corporation (CRGN) is one of those names.
The Company is dedicated to improving the lives of patients by developing
novel pharmaceutical products that address unmet medical needs.
CuraGen was founded when the massive undertaking to sequence the
human genome was just beginning. The Company's strategy was based
on discovering novel ways to combat disease through an understanding
of how genes and their resulting proteins function within the human
genome. The Company is now transforming itself into a more oncologyfocused
biotechnology company. They have Velafermin for oral mucositis
in Phase II and Belinostat for T-cell lymphoma, ovarian cancer, and
Leukemia in Phase II. CRGN also has two other candidates in earlier
phases. But one of the most attractive aspects is their $155.2 million in
cash and marketable securities that reside on the balance sheet while
their market cap is $80 million. On the flip side, the Company does have
$110M worth of subordinate debentures, a $475 million accumulated
deficit, and new management that will have to climb the learning curve
and decelerate the cash burn. In any event, with a couple of Phase II
drugs in the pipeline and substantial cash, along with new management
to turn the corner in becoming an oncology focused biopharm, the Company
easily becomes one to follow. Investors would be wise to watch.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



(CVTX)
CV Therapeutics Seeks Expansion of
Product Labeling for Ranexa(R) in Angina
CV Therapeutics (CVTX) submitted a supplemental new drug application
to the FDA seeking an expansion to the approved product labeling
for Ranexa(R)(ranolazine extended-release tablets). Ranexa
is currently indicated for the treatment of chronic angina, in patients
who have not achieved an adequate response with other antianginal
drugs, and should be used in combination with amlodipine, beta-blockers
or nitrates. The Company is requesting a new indication that significantly
reduces cautionary language. The Company believes that
data from the MERLIN TIMI-36 study could support expansion of the
existing Ranexa indication to first line angina. Angina (chest pain) occurs
when the heart's muscular wall is not getting enough oxygen. By
relaxing the blood vessels, antiangina drugs reduce the heart's work
load and increase the amount of oxygen-rich blood that reaches the
heart. Commonly used antiangina drugs include isosorbide dinitrate
(Isordil, Sorbitrate, and other brands) and nitroglycerin (Nitro-Bid, Nitro-
Dur, Nitrolingual Spray, Nitrostat Tablets, Transderm-Nitro, and other
brands). The Company is focused on the discovery, development and
commercialization of new small molecule drugs for the treatment of cardiovascular
diseases. Small molecule therapeutics can frequently be
administered orally on an outpatient basis. In contrast, large molecule
therapeutics, such as proteins or monoclonal antibodies, can very rarely
be formulated to accommodate oral outpatient administration. All product
sales are currently derived from Ranexa to customers within the
United States. Net product sales of Ranexa for the quarter ended June
30, 2007 were $15.3 million which represented an increase of 28%,
compared to $12.0 million of net product sales revenue recorded in the
quarter ended March 31, 2007. Another product candidate under development
is regadenoson, a selective A2A-adenosine receptor agonist for
potential use as a pharmacologic stress agent in myocardial perfusion
imaging studies. The Company submitted a new drug application for
regadenoson to the FDA in May 2007. Regulatory action on the application
is expected in the first half of 2008. As of June 30, 2007, the Company
had cash, cash equivalents and marketable securities of $216.5
million and an accumulated deficit of $1.2 billion. The Company expects
its R&D expenses to decrease in the second half of 2007, compared to
the first half of 2007, due to the completion of the MERLIN TIMI-36 clinical
study and the second regadenoson Phase 3 study. Cantor Fitzgerald
has a Buy rating on CVTX after an encouraging increase in Ranexa
growth in August. The firm anticipates growth in prescriptions to continue
in September. Ranexa was the first new pharmaceutical approach
to treat angina in the United States in more than 20 years. An additional
indication for Renexa as a first line angina treatment, if approved, could
significantly impact revenues.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



(HINT)
Hill International Awarded 3-year, $13.6M
Contract to Build Landmark Tameer Towers
Hill International (HINT) has been awarded a 3-year contract by Tameer
Holdings Investment to provide project management services for
the landmark Tameer Towers for an estimated value of approximately
$13.6M. Anticipated construction costs will total $1.6B, located in the
Centre Business District of the Shams Abu Dhabi project on Reem Island.
Consisting of six towers, the development includes a state-of-theart
300-meter-high office tower, 4 residential towers with heights varying
from 30-50 floors, and a 7-star luxury hotel. Tameer Towers is intended
to become an icon of Abu Dhabi, similar to the Petronas Towers of Kuala
Lumpur, the Eiffel Tower of Paris, or the Burj Al Arab of Dubai. Construction
began in September 2007 and is expected to be completed by
November 2010.

Story Stocks.......


Updated: 01-Oct-07

Quotes at time of story, top stories today: (Acxiom Corp.)  (Walgreens)  (United Parcel Service)  (Nokia)  (Citigroup) 


Oct 01 2007 09:34AM ******

Acxiom Corp.

A $2.25 billion buyout agreement between Acxiom Corp. (ACXM, 19.79), provider of information management systems, and private equity firms ValueAct Capital Partners LP and Silver Lake Parters has fallen apart amid a wave of economic uncertainty and credit market fears. Negotiations to break off the deal were initially reported in The Wall Street Journal, but various sources have since confirmed the deal has officially fallen through.

Just a few months ago private equity buyouts were booming, but tightening credit markets have made for dubious deal terms, leaving would-be buyers uncertain of their investment returns.  Recently, Harman International (HAR, 86.52)and SLM Corp. (SLM, 49.67) suffered setbacks to their buyouts after suitors second guessed the transactions.

In the face of economic uncertainty, Acxiom posted first quarter adjusted earnings of $0.09 per share in July, $0.12 less than the consensus estimate.  As of last week's market close, shares of ACXM were trading at $19.79, well below the initial cash offer of $27.10 offered in May.

Getting out of the deal will likely come with a substantial termination fee, estimated at between $30 million and $40 million in total, according to The Journal. 

--Jeffrey Ham, Briefing.com





Oct 01 2007 09:27AM ******

Walgreens

Drugstore company Walgreens (WAG 47.24) has a commendable earnings history.  It isn't an unblemished history, though.  Occasionally, Walgreens has come up short of the consensus EPS estimate by a penny or two.  Today it caught us, and everyone else, by surprise in reporting a fiscal fourth quarter profit of $0.40 per share that was seven cents below expectations and down 2.4% from last year.

Walgreens cited lower generic drug reimbursements, higher salary and store expenses, and higher advertising costs for the disappointment.  The quarterly performance was all the more disappointing given that the company had a lower tax rate and fewer shares outstanding than the year-ago period.

WAG is indicated 10% lower in pre-market trading.  The response is understandable.  A miss this big begs the question, why didn't Walgreens issue a warning ahead of time?  Doing so might have limited the fallout.  Now, it simply breeds confusion on the issue of whether this is a one-off situation or the start of something more that will prompt a downward revision to long-term earnings growth projections.

To its credit, Walgreens had a record fiscal year as net earnings increased 16.6% to $2.04 billion while diluted EPS jumped 18% to $2.03.  Total sales increased 13.4% to $53.8 billion and comparable-store sales surged 8.1%.

The market isn't going to spend much time looking back.  Fortunately, demographic trends augur well for Walgreens.  That consideration, and its strong financial profile, are key reasons why we believe the issue remains a suitable holding for the long-term investor. 

Given the fourth quarter surprise, though, WAG will be in the market's penalty box for a while as the market waits on Walgreens to get its expense structure in line and to validate the view that the fourth quarter disappointment was indeed a one-off situation.

--Patrick J. O'Hare, Briefing.com





Oct 01 2007 09:22AM ******

United Parcel Service

United Parcel Service (UPS, 75.10) announced late Sunday that a tentative agreement has been made with the International Brotherhood of Teamsters.  If ratified, the new agreement will increase wages annually while allocating additional funds to pension and benefit trust accounts over five years. 

According to reports, the Teamsters wanted to establish a new agreement before the U.S. Pension Protection Act takes effect on January 1.

The UPS announcement follows last week's labor agreement between General Motors (GM, 36.70) and the United Auto Workers Union. 

--Jeffrey Ham, Briefing.com





Oct 01 2007 09:15AM ******

Nokia

Nokia Corp. (NOK 37.93) agreed to acquire navigation software maker Navteq Corp. (NVT 77.97), in an $8.1 billion deal to expand its mobile services offerings and further strengthen its position in the fast-growing mobile navigation area. 

Nokia shares, which are up about 87% in 2007, were indicated more than 4% lower in pre-market activity, while Navteq shares edged slightly higher following the announcement on Monday.  Other navigation companies such as Garmin (GRMN 119.40) and Trimble Navigation (TRMB 39.21) also traded lower in sympathy. 

Under the agreement, Nokia will pay $78 per Navteq share, or approximately $8.1 billion in total.  The deal has already been approved by the board of directors of both companies, but is still subject to customary closing conditions.  It is expected to close in the first quarter of 2008.

Nokia does not expect the deal to affect share buy-backs or its future cash flow distribution strategy in terms of dividends and buy-backs.  The acquisition is expected to be dilutive to earnings in 2008 and 2009 on a reported basis.  However, on a cash basis, it is expected to be only slightly dilutive next year and slightly accretive in 2009. 

--Richard Jahnke, Briefing.com





Oct 01 2007 08:22AM ******

Citigroup

Citigroup (C 46.67) warned Monday its third quarter earnings would fall approximately 60% from a year ago, due to dislocations in the mortgage-backed securities and credit markets and deterioration in the consumer credit environment.  Its shares traded lower on the news, losing more than 2% in pre-market activity. 

Citigroup attributed the substantial decline to weak performance in fixed income credit market activities, write-downs in leveraged loan commitments, and increases in consumer credit costs. 

Given the recent disruption in the credit markets, triggered by the meltdown in the sub-prime lending industry, the company expects to write-down about $1.4 billion on funded and unfunded highly leveraged finance commitments.  It will record a loss of roughly $1.3 billion on the value of sub-prime mortgage-backed securities and a loss of about $600 million in fixed income credit trading due to significant market volatility. 

Although market conditions remain difficult to predict, the company said it expects to return to a normal earnings environment in the fourth quarter. 

--Richard Jahnke, Briefing.com

Tech Stocks.......


3 Com (COMS 4.94 +1.26) confirmed that it has has signed a definitive merger agreement to be acquired by affiliates of Bain Capital Partners, for approx $2.2 bln in cash. Under the terms of the agreement, shareholders will receive $5.30 in cash for each share of COMS common stock they hold. The Board of Directors of COMS has unanimously approved the merger agreement and has resolved to recommend that COM's shareholders adopt the agreement.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>


RF Microdevices (RFMD 6.73 +0.25) announced plans to expand its compound semiconductor manufacturing capacity to support growth expectations in the Company's Cellular and Multi-Market product groups. RFMD anticipates increased demand for its industry-leading compound semiconductor process technologies as a result of favorable market trends in the Company's primary markets. RFMD is currently increasing its manufacturing levels of both GaAs HBT and GaAs pHEMT in order to satisfy immediate forecasted demand.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



Boenning & Scattergood initiated Comtech (CMTL 53.49 -0.10) with a Market Outperform and $70 tgt as firm believes at least three factors make the Comtech story especially compelling: 1) Market leadership in all three of its operating segments: Telecommunications Transmissions, Mobile Data Com, and RF Amplifiers. 2) Value-add technology that provides customers with a compelling ROI and quick payback period. 3) Expanding global demand for bandwidth should serve as a catalyst for all of Comtech's products in future years.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



AmTech  lowered their ests on Advanced Micro (AMD 13.20 -0.08) for Q3, FY07 and FY08. They believe the co's late Barcelona introduction and disappointing early performance are an early indication of a bad marriage of process technology and design that will be hard to fix before a move to 45nm is required. The firm expects AMD to deliver on at least a few of the potential cost savings initiatives, but predicting which initiatives is the problem they say. They are lowering their tgt to $17 from $19.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



Collins Stewart initiated Riverbed (RVBD 40.39 -1.43) with a Market Perform as firm believes RVBD will continue to benefit from its technology lead, broader market acceptance and distribution. However, they find the shares priced for perfection given our expectations for increased competition, eventual low-end commoditization and a gradual, rather than explosive build for WAN client software, partly due to competitive ASPs. Firm would become more positive on a 10% pullback in the shares.

In Play.......



Oct 02 2007 08:04AM ******

IntercontinentalExchange reports ICE Futures Europe reached a record 598,651 contracts traded in September ...





Oct 02 2007 08:04AM ******

Sulphco clarifies yesterday's registration statement Co announced  that on October 1, 2007, it filed a registration statement on Form S-3 to register up to 9,087,859 shares of its common stock that are being offered by selling security holders. The majority of the shares being registered relate to financing transactions entered into by the co and the selling security holders in March and April 2007 (which are more fully described in the registration statement). All of the shares of common stock being offered are being offered and sold by the selling security holders. Accordingly, although the co may receive proceeds from time to time from the exercise of warrants and options by the selling security holders, it will not receive any proceeds from the resale of the shares by the selling security holders. This registration statement replaces the registration statement to register these same shares that was initially filed on May 29, 2007 and later withdrawn on July 18, 2007.





Oct 02 2007 08:02AM ******

InfoLogix Acquires Healthcare Informatics Associates; expects the transaction to be accretive to '07 EPS ...





Oct 02 2007 08:01AM ******

Walgreen reports September comparable same store sales +4.7% 





Oct 02 2007 08:01AM ******

American Science & Engineering Receives $3.4 Million Order from Middle East Customer for Gemini Parcel Systems ...





Oct 02 2007 08:00AM ******

Fundtech's IGTplus Financial Messaging Gateway Deployed by UBS for US Dollar and Swiss Franc Clearing ...





Oct 02 2007 07:53AM ******

On The Wires Science Applications International (SAI) announces it won a contract from the Naval Surface Warfare Center, Carderock Division, to provide Shipboard Instrumentation and Systems Calibration to support the Navy's engineering agent for Calibration by providing programmatic and engineering services. This cost-plus-fixed-fee, SEAPORT-e Task Order has a 19-month base period and three options of varying lengths, with a total value of $25 mln if all options are exercised... Nokia's (NOK) new partnerships with content brands brings a range of high-quality mobile videos into compatible Nokia Nseries device owners. The new partners announced are to join YouTube and Reuters in providing mobile video content for the Nokia Video Center.





Oct 02 2007 07:38AM ******

R.H. Donnelley announces proposed offering of additional $500 mln of senior notes 





Oct 02 2007 07:37AM ******

Dean Foods lowers Q3, Y07 EPS guidance; co announces reduction in workforce Co sees Q3 EPS of approx $0.15, compared to previous guidance of $0.24-0.28, vs $0.26 consensus. Co sees Y07 EPS of approx $1.25, compared to previous guidance of "the low end" of $1.52-1.58 vs $1.46 consensus. CEO says, "Rapidly increasing and record high dairy commodity costs have created a very challenging operating environment and 2007 results have been well short of our expectations. The third quarter has been particularly challenging as dairy commodity costs have risen sharply, hitting all time highs. This is by far the most difficult operating environment in the history of the company, reinforcing the importance of the long-term strategic initiatives we have underway." Co also announced a reduction in workforce that is expected to affect approx 600-700 positions. Implementation will begin immediately with a voluntary reduction program followed by an involuntary reduction, if necessary. The program is expected to conclude by late October.





Oct 02 2007 07:31AM ******

Genvec receives second-year funding from NIAID for HIV vaccine contract Co announces that the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, has executed its first option period (year two) under a previously announced five-year, $52 mln contract with GenVec for the production of HIV vaccines. GenVec will receive up to $5.1 mln for the second year of activities. These funds will support the transfer and scale-up of the co's manufacturing and purification technologies to the NIAID Dale and Betty Bumpers Vaccine Research Center's Vaccine Pilot Plant in Frederick, Maryland, which produces materials for clinical research.





Oct 02 2007 07:31AM ******

TASER says human studies and analytical reports released analyzing cardiovascular and physiologic effects of TASER X26 Co announces that 10 new medical and scientific study posters, abstracts, and papers were published that document recent medical and scientific studies of TASER technology. All of these studies affirmed the general safety of the TASER electronic control device. Six of these studies were presented at the Fourth Mediterranean Emergency Medicine Congress.





Oct 02 2007 07:31AM ******

NASDAQ to acquire Boston Stock Exchange and key exchange assets Co announced it has entered into a definitive agreement to acquire the Boston Stock Exchange, including the holding company, the Boston Equities Exchange, the Boston Stock Exchange Clearing Corporation, and BOX Regulation. Along with these businesses, NASDAQ will acquire an SRO license for trading both equities and options. NASDAQ's acquisition of the B.S.E. Group is valued at approximately $61 mln. NASDAQ will not acquire an interest in the Boston Options Exchange from the B.S.E. However, a regulatory framework for the B.O.X. market will remain in place. NASDAQ, through BOXR, will operate the regulatory services provider to the B.O.X., which is an options trading facility of the B.S.E.. NASDAQ and B.O.X. are discussing a plan regarding the future regulatory structure for B.O.X. As previously noted, NASDAQ anticipates organically launching The NASDAQ Options Market, a price/time priority options market in December 2007, subject to SEC approval.





Oct 02 2007 07:31AM ******

Cameron board of directors approves a 2-for-1 stock split to be effected in the form of a stock dividend; renews stockholder rights plan 





Oct 02 2007 07:28AM ******

NASDAQ halted, news pending 





Oct 02 2007 07:22AM ******

Citigroup to acquire remaining stake in Nikko Cordial through share exchange Co announced that it has reached an agreement with Nikko Cordial to acquire all issued shares of Nikko Cordial that Citi does not already own in exchange for shares of Citigroup. Under the terms of the agreement, Nikko Cordial's minority shareholders will be entitled to receive C shares with an expected value at the time the exchange ratio is determined of Yen 1,700 per Nikko Cordial share.





Oct 02 2007 07:11AM ******

On The Wires CB&I (CBI) announces it has been selected to participate in a major expansion project at a refinery in Alabama. CBI's contract value is estimated in excess of $160 mln... Iron Mountain (IRM) announces its acquisition of R.M.S. Services, a $27 mln records management co. Terms of the deal were not disclosed... Websense (WBSN) announces that the High Court of Justice of England and Wales has sanctioned the Scheme of Arrangement to implement the recommended offer for SurfControl plc by Websense S.C. Operations, a wholly owned subsidiary of Websense.





Oct 02 2007 07:03AM ******

ICF International awarded DHS contract valued up to $15 mln for new agency program Co announces it won a new contract with the U.S. Department of Homeland Security to assist the agency in the implementation of the new Chemical Facility Anti-Terrorism Standards. The contract, valued up to $15 mln, has a base period of one year with four option years. The first year is funded at $2.8 mln.





Oct 02 2007 07:03AM ******

ISIS Pharm announces it earns $5 mln milestone payment from Ortho-McNeil for initiation of phase 1 study of ISIS 325568 CO announces it has earned $5 mln from Ortho-McNeil, a Johnson & Johnson co, for achieving the first development milestone of initializing the Phase 1 clinical trial of ISIS 325568. The collaboration between Isis and OMI, announced on September 13, 2007, includes the licensing of two second-generation antisense drugs, ISIS 325568 and ISIS 377131, both of which represent novel approaches for the treatment of metabolic disease. ISIS 325568 was designed to selectively inhibit the production of glucagon receptor and has demonstrated improved glucose control in animal models of Type 2 diabetes.





Oct 02 2007 07:02AM ******

Pro-Pharamceutical names Anthony Squeglia CFO Co announced Anthony Squeglia has been named Chief Financial Officer, and Steven Schubert Vice President, Finance on a consulting basis. Mr. Squeglia succeeds Carl Lueders who resigned to pursue other interests. From 2003 to present, Mr. Squeglia was Vice President of Investor Relations for the Co and was instrumental in the Co's listing on the Amex, as well as in its fund-raising activities.





Oct 02 2007 07:02AM ******

Columbia Labs says vaginal progesterone gel may improve infant outcomes and reduce the rate of preterm birth in women with a short cervix in mid-pregnancy Co annnounces that babies born to women with high-risk pregnancies treated with Prochieve 8% appear to be less likely to need intensive care than babies born to mothers treated with placebo. The data are published in the October issue of Ultrasound in Obstetrics & Gynecology.





Oct 02 2007 07:02AM ******

Biopure announces that a 1-for-5 reverse stock split became effective at 12:01 a.m. Oct 2, 2007 





Oct 02 2007 07:01AM ******

PetroQuest Energy increases Q3 production guidance and updates operating activities Co announced that the co is increasing its third quarter production guidance to approximately 85.5-87.5 MMcfe per day from its previously issued guidance of 82-87 MMcfe per day. The co is currently evaluating its previously released full year 2007 production guidance and expects to provide an update in conjunction with its third quarter earnings release. Operations Update In the Arkoma Basin, the co has installed production tubing on its fifth operated horizontal Woodford Shale well and it has tested at rates as high as 4.2 MMcfe per day, up from its previously reported test rate of approximately 2.6 MMcfe per day. The well continues to unload its fracture fluids and the co turned the well to sales this past weekend.





Oct 02 2007 06:59AM ******

Pepsi Bottling beats by $0.10, reports revs in-line; guides FY07 EPS above consensus Reports Q3 (Aug) earnings of $0.99 per share, excluding non-recurring items, $0.10 better than the Reuters Estimates consensus of $0.89; revenues rose 7.8% year/year to $3.73 bln vs the $3.7 bln consensus. Co issues upside guidance for FY07, sees EPS of $2.15-2.18, excluding non-recurring items, compared to previous guidance of $2.02-2.07, vs. $2.07 consensus.  CEO says, said, "In the third quarter, we delivered record sales and comparable operating income driven by outstanding performance in the U.S. and Canada and in Europe, led by Russia. Our strong top-line growth, gross profit per case improvement and disciplined cost management led to solid profit and cash flow increases."






Oct 02 2007 06:56AM ******

Commerce Bancorp: TD Bank Financial Group to acquire Commerce Bancorp TD Bank Financial Group (TD) and CBH announce that they have signed a definitive agreement for TD to acquire CBH in a 75% stock and 25% cash transaction valued at US$8.5 bln... Under the agreement, Commerce shareholders will receive 0.4142 shares of a TD common share and US$10.50 in cash in exchange for each common share of Commerce Bancorp Inc. The consideration was negotiated on the basis of US$42.00 per share value for Commerce Bank. The transaction value based on the October 1, 2007 closing price of TD common shares is $42.37... On a GAAP basis, the transaction is expected to be 28 cents dilutive in fiscal 2008 and 22 cents dilutive in 2009 to TD's earnings, and 10 cents dilutive in 2008 and flat in 2009 on an adjusted basis.





Oct 02 2007 06:18AM ******

S&P futures vs fair value: -1.3. Nasdaq futures vs fair value: -2.3.





Oct 02 2007 06:18AM ******

European Markets FTSE...6526.60...+20.40...+0.3%. DAX...7964.32...+41.90...+0.5%.





Oct 02 2007 06:18AM ******

Asian Markets Nikkei...17046.78...+200.82...+1.2%. Hang Seng...28199.75...+1057.28...+3.9%.





Oct 02 2007 06:07AM ******

On The Wires Document Sciences (DOCX) announces a partnership with Volante Technologies to automate the production and transmission of trade confirmations over a range of messaging systems... Evolving Systems (EVOL) announces that Malaysia's leading telecom carrier has selected the co's Tertio Service Activation solution.





Oct 02 2007 06:04AM ******

Vector Capital to acquire Printronix for $108 mln in cash Co announces that it has signed a definitive agreement to be acquired by Vector Capital. Under the terms of the agreement, Printronix stockholders will receive $16.00 in cash for each share of Printronix common stock, representing a total price of $108 mln.





Oct 02 2007 04:39AM ******

On The Wires EDS (EDS) announces the UK Ministry of Defence has approved an amendment to the Defence Information Infrastructure contract; amendment enables EDS to increase its previously stated estimates for revenue from the MoD DII contract to 2015 by $489 mln.





Oct 02 2007 03:35AM ******

Polycom announces anticipated results for Q3 Co expects to report net revenues for Q3, in the range of $235 mln to $239 mln, compared with net revenues of $173.2 mln in Q306. Additionally, the co expects to report EPS for Q3 in the range of $0.33 and $0.35 on a non-GAAP basis, compared with $0.27 per diluted share in Q306, and between $0.19 and $0.21 on a GAAP basis, compared with $0.19 per diluted share for the comparable period last year. Reuters Consensus Estimates calls for Q307 non-GAAP EPS of $0.35 and revenue of $244.45 mln.





Oct 02 2007 03:31AM ******

Ocean Power Technologies receives additional $1.9 mln funding for U.S. Navy project Co announces that it has received additional funding of $1.9 mln for its on-going contract with the U.S. Navy to install the co's PowerBuoy systems off the island of Oahu.





Oct 02 2007 01:09AM ******

On The Wires Sony (SNE) and Qimonda AG (QI) announce that they have signed an agreement to found the joint venture Qreatic Design; the scope of the joint venture is the design of high-performance, low power, embedded and customer specific DRAMs for consumer and graphic applications.





Oct 02 2007 01:08AM ******

EFJ's EFJohnson subsidiary receives additional $1 mln order from DoD Co announces that its EFJohnson subsidiary has received an order from the DoD following the original $76 mln order announced on December 11, 2006. With this order, the co has announced follow-on orders in excess of $8 mln during 2007. The latest $1 mln order calls for EFJohnson to provide the DoD with additional Project 25 compliant portable radios.





Oct 02 2007 01:04AM ******

EFJ says revenues and earnings will be lower than previous guidance Co issues downside guidance for Q3 (Sep), sees Q3 (Sep) revs of $32.0-33.5 mln vs. $43.02 mln Reuters Estimates consensus. Co issues downside guidance for FY07 (Dec), sees FY07 (Dec) revs of $160-170 mln vs. $186.96 mln consensus. Co also announces it expects '07 income of $1 mln and a loss of $2 mln, vs its initial projection of $7 mln to $10 mln. Co says that the decline of the market for its Transcrypt product has been "significant." They expect it will drop to less than $5 mln for FY07 from an initial projecton of $20 mln.

CHINA RELATED NAMES SEE INCREASED MOMENTUM:

China. In the past few trading
days, multiple names related to the country have seen incredible volumes and price spikes. The
increased speculative nature in these momentum names have message boards and chat rooms
clamoring the Olympics, the weak dollar, and the country's hot economy as reasons behind the
movement. So the next question is how long it can last? Well the Olympics in Beijing are less than
a year away with many noting the country isn't quite ready to host something of that magnitude.
The dollar could continue to weaken with additional Fed rate changes and a slowing economy.
Many have already noted that the Chinese economy has all the ingredients for a bubble that will
eventually burst, though none can give a time frame. What is known is that speculative buying
on too many names is taking place now causing a dangerous game of musical chairs. China
Natural Resources Inc. (CHNR) could be one of those names. Shares have risen spiked from
under $14 to highs over $50 in just 4 trading days. The Company makes and sells dry, natural
rubber and liquid latex. During Thursday's session the Company responded to requests that they
comment on the recent increases in the price and trading volume of the Company's common
shares. The Company noted that there had been no significant developments in their business
or operations that would explain the recent increases save for those that have previously been
publicly reported. Their latest news report was an interim earnings release for their fiscal second
quarter of 17c on $4.35 million in revenue. China Technology Development Group (CTDC)
focuses on developing ingredients for health food products and food supplements utilizing bioactive
components of bamboo to enter the fast growing Chinese nutraceutical market. Besides
that, it is also one of the leading network security solution providers in China. Shares of CTDC
have spiked from just below $7 to over $10.50 before closing in the $9 area on Thursday. Their
latest news release was the retention of investor relation counsel. China Architectural Engineering
(RCH) shares were around $5 4 days ago. Thursday's high saw them trading at over $27.
The Company recently became a public stock through a reverse merger. General Steel Holdings
Inc. (GSI) is engaged in the manufacturing of hot-rolled steel sheets used in the construction of
small agricultural and vehicles. Shares gained 62% on Thursday, rallying from below $10 to over
$15 on no relevant news. The equity began trading on the AMEX during Wednesday's session.
The list could go on and on.

AFTER HOURS - TOP STORY
AFP Imaging Announces Genexa Medical
to Become Exclusive Canadian Distributor
AFP Imaging Corporation (AFPC), and its DENT-X division, announced
that Genexa Medical Inc. has become the exclusive Canadian
distributor for AFP Imaging's NewTom 3-D Cone Beam Computed
Tomography Dental Scanners and other technologies. Genexa Medical
had served as one of several Canadian distributors for DENT-X.
AFP estimates Canadian sales in the next 12 months to reach $4M
and that Genexa will complete approximately 8-10 NewTom Canadian
sales within the next 90 days.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>



AFTER HOURS HEADLINES.......

SYMBOL    NEWS
VSTY Announces Transfer to Nasdaq Capital Market.

CLUB
CEO Giardina Resigns for Health Reasons; Alimanestianu
Succeeds.

VRUS Accesses up to $30 Million of Working Capital.

GDCRF
Grants Aggregate of 591,000 Stock Options; Subject to 4-Month
Hold.

KSW Awarded Two Downtown Projects.

SABA
Q1 Adj EPS 0c vs (4c) Beats (1c) Est; Guidance Below
Consensus.

VRYAF
Undisclosed Multi-Billion Partner Purchases Additional Software
License.

UFI Treasurer Ronald Smith Replaces William M. Lowe, Jr. as CFO.

PXIA
Agrees with Source Global to Complete $46,250,000 Acquisition
of Verticals.

DMAN Q2 Adj EPS (2c) vs 1c Meets (2c) Est.

NASI Announces Extension of Loan Agreement.

MEH Receives Request under Hart-Scott-Rodino Act.

DSCM Announces Major Agreement with Revolution Health.

The mini-uptrend pause, which started Tuesday, caused the market indices to test their support levels, and the INDU (DJIA) fell slightly below 14,000. Nevertheless, indications are that this near-term correction in the market will be short, shallow and mainly sideways.


There are some early signs that the indices may stop correcting downward, and start to ratchet up again, maybe sometime today. The trade-term indicators are mixed. Some are neutral and some are oversold. An upward rotation in the QQQQ started about 3PM yesterday, and INDU and INX formed bases at the same time. Whether and when intraday the three indices carry through with a rally, as early as today, may depend on catalytic economic news this morning. News with such potential is discussed below along with several stocks in the news.

With a near-term rally expected shortly, this is a good time to examine uptrending stocks.
Absent the recent strength in tech and energy shares.

Technology issues were battered by weakness in semiconductor shares as Morgan Stanley initiated coverage of Intel , Advanced Micro Devices and Nvidia, with underperform ratings due to an "aggressive price environment" and an inventory glut. SanDisk shares dropped 2.9% in concert with weakness in Micron Technology, off 7.7%, which printed its third straight quarterly loss on Wednesday. Energy shares came under pressure as the US Energy Department's weekly inventory report disclosed an unexpected gain of 1.2 million barrels in crude, and oil prices dropped 28 cents to below $80 per barrel. Exxon Mobil shares fell 1%, after reaching another 52-week high Tuesday. And ConocoPhillips shares fell 1.7% on company assertions that refining margins in the third quarter would widely miss second quarter levels. In case readers need any reminder of the Fed's import on equity market prices, a recap may be in order. Following Fed interest rate cuts on September 17, the ensuing rally in equity markets generated 4.8% gains in the DJIA, 6.4% in the Nasdaq, and 4.7% in the S&P 500. It was a dismal August nonfarm payroll and its attendant recession concerns that catalyzed Fed members to adopt its more dovish tone, addressing growth concerns at the expense of inflationary ones, and presenting the Street with unexpected 50 bp rate cuts. With the worst of the credit crunch believed behind us, tomorrow's jobs figure may once again prove pivotal to the Fed decision on October 30-31. Yesterday's data suggest nonfarm payrolls have recovered from August lows, growing in line with expectations of 115K, although perhaps indicating a step-up in unemployment to a 4.7% rate. ADP's healthy 58K adds, in line with expectations, do not include government hirings, which are expected to have rebounded in September; initial jobless claims held steady at 317K, up 16K, still signaling a strong jobs market; Challenger job cuts have declined 9.7% from August levels, and 8.1% from a year earlier. Besides the benign jobs data, yesterday's ISM service index further dampened expectations for an additional interest rate cut as it pointed to improved employment and rising inflation numbers, with the index printing at 54.8 in September, well beyond the 50 point expansion level. Both the Bank of England and European Central Bank held rates at current levels, as expected. 

In the corporate corner, Pier 1 shares advanced 9.8% due to insider buying and improved turnaround prospects. Radian shares fell 9.5% on news that Deloitte and Touche had quit as company auditors; the firm recently reported one of its market value collateralized debt obligations of asset-backed securities was in trouble, although S&P has maintained the company's AA-rating. CSX shares fell 2.6% on a lower rating by Morgan Stanley. Bear Stearns (off 0.7%) announced 310 mortgage-business firings; the company will host its semi-annual investor meeting today. Credit Suisse added to its 150 job cuts with 170 more in its commercial mortgage business. Las Vegas Sands shares fell 11.8% as investors realized the rumored 100% revenue gains likely to come in at a still-healthy 55% from Macau growth; Wynn shares dropped 9.9%. However, over the past 52 weeks Las Vegas Sands' shares are up 90%, and Wynn's up 120%. Marriott International posted third quarter results of 31 cents adjusted, topping estimates by one cent.

(HSPO.OB)
CEO Comments on Emergence of
Enlyten(TM) SportStrips(TM)
Interest in HealthSport, Inc. (HSPO) soared in Friday's session,
following a profile the Company's new edible film electrolyte delivery
product, Enlyten(TM) SportStrips(TM). The products were
profiled on CNBC's special segment, "The Business of Innovation."
Scientists and other sports medicine experts at Duke University have recognized
the strip delivery technology as an important breakthrough in combating electrolyte imbalances in
athletes and decreasing exercise-induced cramping. With an innovative and unique delivery method
through the soft tissue of the inner cheek and gum. The Enlyten SportStrips are absorbed faster
and more efficiently by bypassing the digestive system. The electrolyte ingredients are absorbed
directly into the blood stream avoiding efficacy loss prone to gastric absorption.
Several pro and college sports teams have begun using electrolyte replenishment for their athletes
before, during, and after training and games. Athletes and teams such as the Buffalo Bills, Miami
Dolphins and Dallas Cowboys, as well as Michigan State, Notre Dame , Purdue, Texas A&M and
University of Utah are offering this new alternative to traditional hydration products.
Enlyten SportStrips have recently become available in Dick's Sporting Goods (DKS) stores in Ohio
and Kentucky. They will also be distributed by Sports Authority, a major nationwide full-line sporting
goods retailer. Sports Authority will become the first retail distribution partner to offer the Enlyten
SportStrips in all of its 415 stores across 45 states with availability to consumers scheduled for
mid-October.
HealthSport President and CEO, Dan Kelly, told CNBC on Friday, "The Goliath in this industry is
obviously Gatorade. Gatorade has recently been telling NFL teams not to use our strips. He added,
our product is effective in reducing IV procedures for athletes that are one step away from dehydration."
Pepsico's (PEP) Gatorade(R) is trying to counter the entry of the Enlyten(TM) SportStrips(TM) into
the market. According to an unnamed source for Gatorade, " Our product is optimally and superiorly
formulated to provide necessary nutrients. Dehydration prevention requires liquids and electrolytes
and there is little or no evidence to the effectiveness of this new product."
Market share for Coca-Cola's (KO) POWERADE, POWERADE OPTION and AQUARIUS energy
drinks could also be affected.
HealthSport owns two subsidiaries, Enlyten, Inc., to market and distribute HealthSport's products;
and InnoZen, a formulator, developer and manufacturer of edible film strips that deliver drug actives
through buccal (between the cheek and gum) absorption. The Company acquired Innozen in
May 2007. Innozen was the developer of Chloraseptic(R) Sore Throat Relief Strips in June 2003.
Innozen has a distribution and supply agreement with Schering-Plough (SGP) for film strip products
in the cough and cold market.
The Company also recently announced the planned online and retail launch of PediaStrips(TM), an
edible electrolyte strip developed to combat children's dehydration due to illness, on November 1.
PediaStrips replace lost electrolytes associated with symptoms of flu, diarrhea, vomiting or extreme
climates. PediaStrips will be available in Grape, Orange and Berry flavor, but they have no calories,
sugars or carbohydrates.
"We are excited to have a children's product that helps avoid dehydration," said Dan Kelly. "All
too often you hear of children being hospitalized for symptoms of dehydration after having the flu
and we feel it is so important for parents to have a product that offers relief from this problem. The
PediaStrips delivery system ensures that children will get the proper nutrients in a fast and efficient
manner without the added sugars and liquids they may not need, while avoiding the hassles of
measuring the right amount of liquids."
The Company also plans to seek the formulation and development of new thin film products and
other products using various additional oral delivery systems. InnoZen has five patents pending and
has developed numerous trade secrets which it incorporates in the development and manufacturing
process of edible film strips.

New China IPO.......

STV up big first day was a bad start but jumped yesterday and so far today.

• China Digital TV Gains 75 Pct in Debut
AP (Fri, Oct 5) 

52wk Range: 28.75 - 39.99
Volume: 1,121,600
Avg Vol (3m): 14,579,300

Technicals
Record Price High
Most Actives
Percentage Gainer
Price Gainer


Fundamentals
Key Data:
Market Cap (M): $1,553.91 
P/E Ratio: 97.06 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A

Great posts Set.

Quote from: stocky on October 09, 2007, 09:30:40 PM
Great posts Set.

Thanks Stocky !
Good to hear from you...Trade em well my friend 

AFTER HOURS - TOP STORY.......

(LTDI.PK)

Latitude Industries Signs Agreement
with Mercury Marine Worth Over $600,000
Latitude Industries Inc. (LTDI), announced that it has entered into an
agreement with Mercury Marine to distribute their outboard engines.
Mercury Marine, with $2.3 Billion a year in sales, offers a wide variety
of outboard engines from the Four Stroke Verado to the High Performance
Optimax SX race engines of up to 300 horsepower, plus many
additional high performance accessories.

(FREE) and (BHO)
Small Cap Dry Bulk Shippers
Gain Momentum
Wednesday's session saw the Dow lose 85 points as one of its
main components announced delays on their newest product.
Boeing announced a delay on their 787 Dreamliner airplane
causing shares to fall 2.73%. Also contributing to the slide was
disappointing earnings results with many analysts expecting the market to give
up 3-5% over the course of the season on slower earnings growth based on
early reporters.
Monsanto and Alcoa reported earnings lower than expected while Chevron announced that it
would miss their third quarter guidance expectations. Costco Wholesale Corp was one of the
Company's who surprised with a profit rise of 4.7%, topping analyst forecasts.
In the small cap space, a couple of names saw an increase in buying and volume attracting many
momentum players. FreeSeas, Inc. (FREE) shares, spiked during the afternoon half of the session,
reaching a high of $10.40 on no news. The stock closed at $10.24, up 30%, on 1.62 million
shares traded. The Company is a commercial shipping company that operates Handysize and
Handymax vessels in the dry bulk markets. FreeSeas' vessels carry a variety of dry bulk commodities,
including coal, iron ore, and grains, or major bulks, as well as bauxite, phosphate, fertilizers
and steel products, or minor bulks.
The Company recently released earnings which showed year over year growth, though shares
lost over 11% over the following days after the announcement. Earnings displayed that revenue
grew by 19.3% over the same quarter of 2006 and by 44.2% for the first half of 2007 over first
half of 2006.
Net income for the second quarter improved to $1.71 million, compared to a loss of $0.6 million in
the same quarter of 2006 or $0.27 per share, based on 6,290,100 basic shares outstanding, compared
to $0.10 loss per share in same quarter 2006. Net income for the first half of 2007 reached
$2.62 million compared to a loss of $2.26 million in the first half of 2006, or $0.42 per share as of
June 30, 2007 as compared to $0.36 loss per share for the same period in 2006.
On September 27th, the Company announced that the M/V Free Jupiter would undergo an unscheduled
dry-docking to complete repairs following a grounding incident on September 21, 2007
off the coast of the Philippines. The dry-docking was expected to take place after the refloating
of the vessel and completion of the current trip charter. The Company expected that the vessel's
repairs and related expenses would be covered by the vessel's insurance.
The Company also announced that the M/V Free Destiny had been chartered at a rate of $28,000
per day on a spot charter of approximately 70 days. The addition of $1.96 million in revenue could
be the reason for the shares to have received the added attention.
Another name in the space also saw increased volume as also being a dry bulk carrier. B&H Carrier
Limited (BHO) currently owns and operates three IMO Type 2&3 Product / Chemical Carriers,
three Medium Range Product Tankers, two Panamax Product Tankers and seven Combination
Carriers. The seven Combination Carriers include one recently acquired vessel which the Company
holds a 50% interest.
On Wednesday, shares gained 12% on 268 thousand shares traded. Along with FREE, BHO
received the added addition on no news. With earnings from both of these names just around the
corner, investors would be wise to watch.